213 related articles for article (PubMed ID: 32727993)
1. Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis.
Nakamura M; Yamamura T; Maeda K; Sawada T; Mizutani Y; Ishikawa E; Ohashi A; Kajikawa G; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
Intern Med; 2020 Dec; 59(23):3009-3014. PubMed ID: 32727993
[TBL] [Abstract][Full Text] [Related]
2. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?
Rodríguez-Lago I; Benítez JM; Sempere L; Sáez-González E; Barreiro-de Acosta M; de Zárate JO; Cabriada JL
J Clin Apher; 2019 Dec; 34(6):680-685. PubMed ID: 31518013
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis.
Shibuya T; Haga K; Saeki M; Haraikawa M; Tsuchihashi H; Okahara K; Nomura O; Fukushima H; Murakami T; Ishikawa D; Ikeda S; Nagahara A
J Clin Apher; 2020 Sep; 35(5):488-492. PubMed ID: 32767842
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
Ishiguro Y; Ohmori T; Umemura K; Iizuka M
Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
[TBL] [Abstract][Full Text] [Related]
5. A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte-monocyte apheresis combination therapy.
Ishihara H; Watanabe T; Kumei S; Kume K; Yoshikawa I; Harada M
Clin J Gastroenterol; 2024 Feb; 17(1):46-51. PubMed ID: 38041760
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis.
Rodríguez-Lago I; Sempere L; Gutiérrez A; Núñez A; Leo Carnerero E; Hinojosa E; Mora M; Cañete F; Mañosa M; Herrera C; Beltrán B; Forés A; Arjona D; Barreiro-de Acosta M; Khorrami S; Aguirre U; Ginard D; Cabriada JL
Scand J Gastroenterol; 2019 Apr; 54(4):459-464. PubMed ID: 30982369
[No Abstract] [Full Text] [Related]
8. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study.
Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M
J Clin Apher; 2023 Aug; 38(4):406-421. PubMed ID: 36636880
[TBL] [Abstract][Full Text] [Related]
9. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
[TBL] [Abstract][Full Text] [Related]
10. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis.
Hashiguchi K; Takeshima F; Akazawa Y; Matsushima K; Minami H; Machida H; Yamaguchi N; Shiozawa K; Ohba K; Ohnita K; Ichikawa T; Isomoto H; Nakao K
Digestion; 2015; 91(3):208-17. PubMed ID: 25823500
[TBL] [Abstract][Full Text] [Related]
11. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids.
Ohno M; Koyama S; Ohara M; Shimamoto K; Kobayashi Y; Nakamura F; Mitsuru K; Andoh A
Intern Med; 2016; 55(1):25-30. PubMed ID: 26726081
[TBL] [Abstract][Full Text] [Related]
13. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.
Sáez-González E; Moret-Tatay I; Bastida G; Aguas M; Iborra M; Nos P; Beltrán B
J Clin Apher; 2024 Feb; 39(1):e22101. PubMed ID: 38054256
[TBL] [Abstract][Full Text] [Related]
15. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
Yokoyama Y; Kawai M; Fukunaga K; Kamikozuru K; Nagase K; Nogami K; Kono T; Ohda Y; Iimuro M; Hida N; Nakamura S; Miwa H; Matsumoto T
BMC Gastroenterol; 2013 Feb; 13():27. PubMed ID: 23399416
[TBL] [Abstract][Full Text] [Related]
16. Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.
Saito H; Hanafusa N; Kishikawa J; Noiri E; Sunami E; Ishihara S; Watanabe T; Nangaku M
J Clin Apher; 2016 Dec; 31(6):584-586. PubMed ID: 26876484
[TBL] [Abstract][Full Text] [Related]
17. Treatment of a Case of Ulcerative Colitis with Sacroiliitis Using Granulocyte and Monocyte Adsorption Apheresis.
Ichikawa H; Imai J; Mizukami H; Shirai T; Watanabe N
Tokai J Exp Clin Med; 2017 Jul; 42(2):64-66. PubMed ID: 28681364
[TBL] [Abstract][Full Text] [Related]
18. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis in a Patient with Low Bone Mineral Density Due to Fanconi-Bickel Syndrome.
Tanaka M; Nakanishi M; Miyazaki H; Morita R; Eguchi H; Takeda Y; Katayama M; Tanaka M; Bamba M; Shigematsu T
Intern Med; 2021 Aug; 60(15):2413-2417. PubMed ID: 33612684
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
